Cargando…
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S...
Autores principales: | Weinstock, Jonathan, Bader, Yousef H., Maron, Martin S., Rowin, Ethan J., Link, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802466/ https://www.ncbi.nlm.nih.gov/pubmed/26873684 http://dx.doi.org/10.1161/JAHA.115.002488 |
Ejemplares similares
-
Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005) -
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018) -
Subcutaneous Implantable Cardioverter Defibrillator: Early
Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017) -
The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014) -
Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
por: Nishii, Nobuhiro, et al.
Publicado: (2017)